Tabrecta (capmatinib) is a prescription medication used for treating adults with non-small cell lung cancer (NSCLC) that has specific mutations in the MET gene as identified by an FDA-approved test. This oral kinase inhibitor specifically targets the MET exon 14 skipping mutation in tumor cells, potentially inhibiting tumor growth. Tabrecta is developed and marketed by Novartis.

The price of Tabrecta without insurance varies by pharmacy, dosage, and quantity. Rx.com compares cash prices at more than 60,000 US pharmacies so you can find the lowest price near you.

Common side effects of Tabrecta may include: Rapid weight gain, swelling in your hands, ankles, or feet, Sudden and severe stomach pain, nausea, vomiting, fever, lightheadedness, Chest pain, cough, fever, trouble breathing, Dark urine or pale stools, loss of appetite, yellow skin or eyes, Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing. This is not a complete list — consult your pharmacist or doctor for full side effect information.

Generic versions may be available for Tabrecta. Generics contain the same active ingredients as brand-name drugs and are typically 80–90% cheaper. Search Tabrecta on Rx.com to compare generic and brand prices at pharmacies near you.

The cheapest pharmacy for Tabrecta depends on your location and dosage. Rx.com compares prices at CVS, Walgreens, Walmart, Kroger, Costco, and thousands of independent pharmacies. Enter your ZIP code on Rx.com to find the lowest price for Tabrecta near you.